+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Alexion Pharmaceuticals - logo

Alexion is a global biopharmaceutical company focused on developing and delivering life-transforming therapies for patients with devastating and rare diseases. Alexion developed Soliris for the treatment of patients with paroxysmal nocturnal hemoglobinuria and atypical hemolytic uremic syndrome. Soliris is approved in more than 50 countries for PNH and more than 40 countries for aHUS. Alexion's company headquarters are based Cheshire, Connecticut, United States.

Antidotes Market Report 2025 - Product Thumbnail Image

Antidotes Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
Hypercholesterolemia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Hypercholesterolemia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • October 2022
  • 210 Pages
  • Global
From
Paroxysmal Nocturnal Hemoglobinuria Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Paroxysmal Nocturnal Hemoglobinuria Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • June 2022
  • 131 Pages
  • Global
From
Morquio Syndrome Drugs - Global Strategic Business Report - Product Thumbnail Image

Morquio Syndrome Drugs - Global Strategic Business Report

  • Report
  • September 2025
  • 467 Pages
  • Global
From
Rare Diseases Treatment Market Report 2025 - Product Thumbnail Image

Rare Diseases Treatment Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Nasal Drug Delivery Technology Market Report 2025 - Product Thumbnail Image

Nasal Drug Delivery Technology Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Viral Gastroenteritis Market Report 2025 - Product Thumbnail Image

Viral Gastroenteritis Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Rare Hematology - Global Strategic Business Report - Product Thumbnail Image

Rare Hematology - Global Strategic Business Report

  • Report
  • September 2025
  • 194 Pages
  • Global
From
Transthyretin Amyloid Cardiomyopathy - Pipeline Inisght, 2021 - Product Thumbnail Image

Transthyretin Amyloid Cardiomyopathy - Pipeline Inisght, 2021

  • Clinical Trials
  • September 2021
  • 60 Pages
  • Global
From
Neurofibromatoses Type I (Von Recklinghausen's Disease) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Neurofibromatoses Type I (Von Recklinghausen's Disease) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • November 2022
  • 72 Pages
  • Global
From
Nephrology Drugs - Global Strategic Business Report - Product Thumbnail Image

Nephrology Drugs - Global Strategic Business Report

  • Report
  • September 2025
  • 386 Pages
  • Global
From
Transthyretin (ATTR or Prealbumin or TBPA or TTR) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Transthyretin (ATTR or Prealbumin or TBPA or TTR) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • September 2022
  • 85 Pages
  • Global
From
Amyotrophic Lateral Sclerosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Amyotrophic Lateral Sclerosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • September 2022
  • 672 Pages
  • Global
From
Primary Immunodeficiency Disorders - Global Strategic Business Report - Product Thumbnail Image

Primary Immunodeficiency Disorders - Global Strategic Business Report

  • Report
  • September 2025
  • 280 Pages
  • Global
From
Tumor / Cancer Markers - Global Strategic Business Report - Product Thumbnail Image

Tumor / Cancer Markers - Global Strategic Business Report

  • Report
  • September 2025
  • 180 Pages
  • Global
From
Rare Disease Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa) - Product Thumbnail Image

Rare Disease Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

  • Report
  • January 2024
  • 283 Pages
  • Global
Global Genome Editing Market, 2023-2035: Focus on Technology, Industry Trends and Forecasts - Product Thumbnail Image

Global Genome Editing Market, 2023-2035: Focus on Technology, Industry Trends and Forecasts

  • Report
  • January 2024
  • 270 Pages
  • Global
From
Bleeding Disorder Drugs - Global Strategic Business Report - Product Thumbnail Image

Bleeding Disorder Drugs - Global Strategic Business Report

  • Report
  • September 2025
  • 488 Pages
  • Global
From
Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment - Global Strategic Business Report - Product Thumbnail Image

Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment - Global Strategic Business Report

  • Report
  • September 2025
  • 126 Pages
  • Global
From
Andersen-Tawil Syndrome (ATS) - Global Strategic Business Report - Product Thumbnail Image

Andersen-Tawil Syndrome (ATS) - Global Strategic Business Report

  • Report
  • September 2025
  • 276 Pages
  • Global
From
Loading Indicator